Market Place
Sourcing Support
Texicare & Virta Offer Free Virtual Type 2 Diabetes Reversal
28 Jan 2026 //
BUSINESSWIRE
Virta Health Report Redefines Metabolic Disease Reversal
12 Nov 2025 //
BUSINESSWIRE
Virta Health Tops $160M Revenue in Metabolic Disease Care
22 Sep 2025 //
BUSINESSWIRE
Virta Health Appoints Laura Walmsley as Chief Commercial Officer
30 Jun 2025 //
BUSINESSWIRE
Virta Health Survey: Guided Off-ramp Boosts Weight Loss Success
11 Jun 2025 //
BUSINESSWIRE
Virta Health Launches Cost Guarantees, 0% GLP-1 Trend, Weight Los
04 Jun 2025 //
BUSINESSWIRE
Banner|Aetna Members See Success With Virta Health Diabetes Program
28 Aug 2024 //
BUSINESSWIRE
Virta Announces Study Proving Its Approach Is an Effective Off-Ramp From GLP-1s
29 Feb 2024 //
BUSINESSWIRE
Virta Health Highlights Improvements In 5-Year Diabetes Reversal Study
06 Jun 2022 //
BUSINESSWIRE
T2D Reversal Leader Virta Health Appoints Shane Henderson as CTO
10 May 2022 //
BUSINESSWIRE
Patients Receiving Virta’s Diabetes Reversal Treatment
02 Feb 2022 //
BUSINESSWIRE
Virta’s Diabetes Reversal Drives Savings of above $10k Per Patient Over 2 Years
15 Sep 2021 //
BUSINESSWIRE
Virta Convenes 20+ Industry Leaders to Explore Bold Solutions
01 Sep 2021 //
BUSINESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.